BACKGROUND: Clinical registries have been created to address questions that are difficult to answer with clinical trials. However, the applicability of registry findings to the general population has been questioned because of concerns over potential bias in the selection of participating hospitals. The purpose of this study was to determine if patients admitted to hospitals participating in a heart failure registry (ADHERE) are comparable with patients admitted to other hospitals, including those admitted to Framingham area hospitals. METHODS: We used a 20% random sample of all Medicare patients discharged during 1984 to 2001 to determine rates of hospitalization, procedure use, and survival after a first admission for heart failure (none in the prior 3 years). Hospitals were classified as participating in the ADHERE registry (n = 189), located within or near Framingham, MA (n = 9), or other (n = 5541). RESULTS: A total of 725,702 first admissions were identified, including 80,338 to ADHERE hospitals and 1716 to Framingham area hospitals. Minimal differences in patient characteristics were noted between patients admitted to ADHERE and non-ADHERE hospitals, although patients admitted to Framingham area hospitals were more likely to be white (95%) than were patients admitted to ADHERE (84%) or other hospitals (87%, P < .0001). Mortality at 1 year was 35.8% for ADHERE, 36.2% for other hospitalized patients, and 32.9% for Framingham patients (P < .0001). Rehospitalization for heart failure at 90 days was 13.0% for following admission to ADHERE, 13.0% to other hospitals, and 16.4% to Framingham hospitals (P = .0004). After adjustment for patient characteristics, differences in outcome between ADHERE and non-ADHERE hospitals remained minimal. CONCLUSION: Patients admitted with heart failure to ADHERE registry hospitals had similar baseline characteristics and outcomes to other patients.
BACKGROUND: Clinical registries have been created to address questions that are difficult to answer with clinical trials. However, the applicability of registry findings to the general population has been questioned because of concerns over potential bias in the selection of participating hospitals. The purpose of this study was to determine if patients admitted to hospitals participating in a heart failure registry (ADHERE) are comparable with patients admitted to other hospitals, including those admitted to Framingham area hospitals. METHODS: We used a 20% random sample of all Medicare patients discharged during 1984 to 2001 to determine rates of hospitalization, procedure use, and survival after a first admission for heart failure (none in the prior 3 years). Hospitals were classified as participating in the ADHERE registry (n = 189), located within or near Framingham, MA (n = 9), or other (n = 5541). RESULTS: A total of 725,702 first admissions were identified, including 80,338 to ADHERE hospitals and 1716 to Framingham area hospitals. Minimal differences in patient characteristics were noted between patients admitted to ADHERE and non-ADHERE hospitals, although patients admitted to Framingham area hospitals were more likely to be white (95%) than were patients admitted to ADHERE (84%) or other hospitals (87%, P < .0001). Mortality at 1 year was 35.8% for ADHERE, 36.2% for other hospitalized patients, and 32.9% for Framingham patients (P < .0001). Rehospitalization for heart failure at 90 days was 13.0% for following admission to ADHERE, 13.0% to other hospitals, and 16.4% to Framingham hospitals (P = .0004). After adjustment for patient characteristics, differences in outcome between ADHERE and non-ADHERE hospitals remained minimal. CONCLUSION:Patients admitted with heart failure to ADHERE registry hospitals had similar baseline characteristics and outcomes to other patients.
Authors: Ryenn West; Li Liang; Gregg C Fonarow; Robb Kociol; Roger M Mills; Christopher M O'Connor; Adrian F Hernandez Journal: Eur J Heart Fail Date: 2011-06-28 Impact factor: 15.534
Authors: Emily P Zeitler; Anne S Hellkamp; Phillip J Schulte; Gregg C Fonarow; Adrian F Hernandez; Eric D Peterson; Gillian D Sanders; Clyde W Yancy; Sana M Al-Khatib Journal: Circ Heart Fail Date: 2016-01 Impact factor: 8.790
Authors: Ilia G Halatchev; Wen-Chin Wu; Paul A Heidenreich; Elma Djukic; Sumitra Balasubramanian; Kelly B Ohlms; Jay R McDonald Journal: Int J Cardiol Heart Vasc Date: 2021-08-25
Authors: Uptal D Patel; Adrian F Hernandez; Li Liang; Eric D Peterson; Kenneth A LaBresh; Clyde W Yancy; Nancy M Albert; Gray Ellrodt; Gregg C Fonarow Journal: Am Heart J Date: 2008-10 Impact factor: 4.749
Authors: Prateeti Khazanie; Li Liang; Laura G Qualls; Lesley H Curtis; Gregg C Fonarow; Bradley G Hammill; Stephen C Hammill; Paul A Heidenreich; Frederick A Masoudi; Adrian F Hernandez; Jonathan P Piccini Journal: JACC Heart Fail Date: 2014-01-25 Impact factor: 12.035
Authors: Lesley H Curtis; Melissa A Greiner; Bradley G Hammill; Lisa D DiMartino; Alisa M Shea; Adrian F Hernandez; Gregg C Fonarow Journal: Circ Cardiovasc Qual Outcomes Date: 2009-06-09
Authors: Warren K Laskey; Ihab Alomari; Margueritte Cox; Phillip J Schulte; Xin Zhao; Adrian F Hernandez; Paul A Heidenreich; Zubin J Eapen; Clyde Yancy; Deepak L Bhatt; Gregg C Fonarow Journal: J Am Heart Assoc Date: 2015-04-22 Impact factor: 5.501
Authors: Boback Ziaeian; Haolin Xu; Roland A Matsouaka; Ying Xian; Yosef Khan; Lee S Schwamm; Eric E Smith; Gregg C Fonarow Journal: BMC Med Res Methodol Date: 2021-02-04 Impact factor: 4.615